Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Zidovudine | Increase | Positive | 307 | ||||||
| Acyclovir | Increase | Positive | 307 | ||||||
| Ganciclovir | Increase | Positive | 307 | ||||||
| Zalcitabine | Increase | Positive | 307 | ||||||
| amphotericin B | 2.5mg/ml | Aspergillus fumigatus | oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t | induce | Positive | 304 | |||
| Terbinafine | 4mg/ml | Aspergillus fumigatus | oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t | induce | Positive | 304 | |||
| itraconazole | 4mg/ml | Aspergillus fumigatus | oxidant-sensing fluorescent probe 2′,7′-dichlorofluorescin diacetate t | induce | Positive | 304 | |||
| tacrolimus | 50 µg/ml | 12hr | INS-1 cells | MitoSOX Red staining to detect mitochondrial superoxide anion (O2−) levels by flow cytometric analysis and e time-lapse images of cells treated for 12 h with MitoSOX Red. | induce | Positive | 322 | ||
| P110 | 1 µM | 2hr | SH-SY5Y cells were treated with P110 (1 µM) followed by incubation of MPP+ (2 mM) for 2 hours. | Mitochondrial superoxide production was determined using the mitochondrial superoxide indicator MitoSOX Red. Total ROS production was determined in SH-SY5Y cells using CM2-HDCFA. | reduce | Positive | 310 | ||
| neomycin | 50 μM | zebrafish | zebrafish lateral line hair | use ROS indicator dye cellROX green ( it labels a number of intracellular compartments, including cytoplasm, nucleus, and mitochondria) | increase | Positive | 315 | ||
| Diflunisal | 558 | rat | hepatocytes | use CM-H2DCFDA to monitor reactive oxygen species | Positive | AC50 (μM) | 40 | ||
| Sulindac sulfide | 109 | rat | hepatocytes | use CM-H2DCFDA to monitor reactive oxygen species | Positive | AC50 (μM) | 40 | ||
| Nimesulide | 574 | rat | hepatocytes | use CM-H2DCFDA to monitor reactive oxygen species | Positive | AC50 (μM) | 40 | ||
| Staurosporine | 2 µM | 24hr | U2OS | mt-roGFP and mitoSOX | increase | Positive | 313 | ||
| camptothecin | 30 µM | 24hr | U2OS | mt-roGFP and mitoSOX | increase | Positive | 313 | ||
| Menadione | 20 µM | 24hr | U2OS | mt-roGFP and mitoSOX | increase | Positive | 313 | ||
| Cisplatin | 150 µM | 24hr | U2OS | U2OS cells stably expressing mt-roGFP and HyPer-red targeted at mitochondria | increase | Positive | 313 | ||
| camptothecin | 30 µM | 24hr | U2OS | U2OS cells stably expressing mt-roGFP and HyPer-red targeted at mitochondria | increase | Positive | 313 | ||
| Ciprofloxacin | Increase | Positive | 307 | ||||||
| Mitoquinone | U2OS | mt-roGFP ratio change (Quantitative representation of the percentage of cell death in cells pre-treated with MitoQ followed by drug treatment or drug alone as indicated for 24 h) | reduce | Positive | 313 | ||||
| Cisplatin | Increase | Positive | 307 | ||||||
| Cyclophosphamide | Increase | Positive | 307 | ||||||
| Gentamicin | 5mM | 10min | rat | isolated rat liver (and kidney) mitochondria | Mitochondrial ROS production can be measured using Amplex Red, a dye that fluoresces dependent on hydrogen peroxide (H2O2) levels. | reduce | Positive | 316 | |
| glyceraldehyde 3-phosphate | 2.5mM | decrease | Positive | 162 | |||||
| dihydroxyacetone phosphate | decrease | Positive | 162 | ||||||
| MG-132 | 20 μM | 24 hr | rat | PC12 cells | Measurement of intracellular ROS formation with DCFH2-DA | increase | Positive | 289 | |
| Amitriptyline | Positive | 197 | |||||||
| 3-morpholinosydnonimine | 150 μM | 24 hr | rat | PC12 cells | Measurement of intracellular ROS formation with DCFH2-DA | decrease | Positive | 289 | |
| Desipramine | Positive | 197 | |||||||
| Valproic Acid | increase | Positive | 197 | ||||||
| Doxorubicin | increase | Positive | 197 | ||||||
| Efavirenz | increase | Positive | 197 | ||||||
| Propofol | increase | Positive | 197 | ||||||
| Ketamine | increase | Positive | 197 | ||||||
| Manganese | 15 mg/l in drinking water | Swiss Albino mice | increase | Positive | 242 | ||||
| Paraquat | 10 mg/kg/week intraperitoneal (i.p.) | 4 weeks | C57BL/6 mice | Positive | 242 | ||||
| Paraquat | 250 μM | 5min | Sprague Dawley rat | brain cultures | Positive | 242 | |||
| Rotenone | 0.1–0.5 nmol/mg protein | Wistar rat | brain isolated mitochondria | increase | Positive | 242 | |||
| Cisplatin | 84.96 ± 3, 158.9 ± 8.2, 372.7 ± 17.5 and 499.5 ± 15.1 μM | 24 hr | Ishikawa, MDA-MB-231, PC-3 and Caco-2 | Intracellular ROS (a) and mitochondrial superoxide were measured by fluorescence intensity of H2DCFDA and MitoSOX respectively. | increase | Positive | IC50 | 299 | |
| Dequalinium Chloride | 14.24 ± 0.59, 57.85 ± 3.59, 93.31 ± 3.21 and 179.2 ± 5.2 μM | 24 hr | Ishikawa, MDA-MB-231, PC-3 and Caco-2 | Intracellular ROS (a) and mitochondrial superoxide were measured by fluorescence intensity of H2DCFDA and MitoSOX respectively. | increase | Positive | IC50 | 299 | |
| Amiodarone | 10 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Chlorpromazine | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Aluminium | 10 mg/kg/day intragastric for 12 weeks | Wistar rats | Positive | 242 | |||||
| Cyclosporin A | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| imipramine | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Maprotiline | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Rotenone | 100 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Tamoxifen | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Troglitazone | 10 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| atorvastatin | 100 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Cerivastatin | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| fluvastatin | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| lovastatin | 10 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| pravastatin | 50 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Simvastatin | 5 µM | 1 hour | Human | HepG2 | High-content screening assay | Increase | Positive | MEC | 306 |
| Methylmercury | 15 mg/l in drinking water | Swiss albino mice | Positive | 242 | |||||